Total investments received (USD): N/A
Round value (USD): 320m
Round investors:
AstraZeneca
Company: Neogene Therapeutics
Industry:
Biotech
Health services









Belgium
Austria
Germany
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain